Analytical Data
-
Gene name
FLJ10769
- Application
-
Alternative Names
NAXD. CARKD. FLJ10769. hCG_32552
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0A7P0T9D8
-
Expression Region
1-347aa
-
AA Sequence
MVTRAGAGTAVAGAVVVALLSAALALYGPPLDAVLERAFSLRKAHSIKDMENTLQLVRNIIPPLSSTKHKGQDGRIGVVGGCQEYTGAPYFAAISALKVGADLSHVFCASAAAPVIKAYSPELIVHPVLDSPNAVHEVEKWLPRLHALVVGPGLGRDDALLRNVQGILEVSKARDIPVVIDADGLWLVAQQPALIHGYRKAVLTPNHVEFSRLYDAVLRGPMDSDDSHGSVLRLSQALGNVTVVQKGERDILSNGQQVLVCSQEGSSRRCGGQGDLLSGSLGVLVHWALLAGPQKTNGSSPLLVAAFGACSLTRQCNHQAFQKHGRSTTTSDMIAEVGAAFSKLFET
-
Molecular Weight
63 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLJ10769 is a recombinant protein that has garnered significant interest in various fields of biomedical research due to its potential roles in cellular processes and disease mechanisms. Initially identified through genomic studies, FLJ10769 has been implicated in several pathways related to cell signaling, metabolism, and immunity. Its exact biological function remains partially understood, but preliminary studies suggest that it may play a crucial role in cell proliferation and differentiation. Research has shown that alterations in the expression of FLJ10769 can correlate with conditions such as cancer and autoimmune diseases, making it a promising target for therapeutic interventions. The recombinant form of this protein allows for more detailed studies, including structure-function analyses and interaction studies with other biomolecules. Additionally, the ability to produce FLJ10769 in a controlled laboratory setting facilitates the development of assays for drug screening and biomarker discovery. Overall, the exploration of FLJ10769 not only enhances our understanding of its biological significance but also provides avenues for innovative approaches in disease treatment and diagnosis.
